AAPM TG 191: Clinical use of luminescent dosimeters: TLDs and OSLDs

Stephen F. Kry, Paola Alvarez, Joanna E. Cygler, Larry A. DeWerd, Rebecca M. Howell, Sanford Meeks, Jennifer O'Daniel, Chester Reft, Gabriel Sawakuchi, Eduardo G. Yukihara, Dimitris Mihailidis

Research output: Contribution to journalArticlepeer-review

117 Scopus citations

Abstract

Thermoluminescent dosimeters (TLD) and optically stimulated luminescent dosimeters (OSLD) are practical, accurate, and precise tools for point dosimetry in medical physics applications. The charges of Task Group 191 were to detail the methodologies for practical and optimal luminescence dosimetry in a clinical setting. This includes: (a) to review the variety of TLD/OSLD materials available, including features and limitations of each; (b) to outline the optimal steps to achieve accurate and precise dosimetry with luminescent detectors and to evaluate the uncertainty induced when less rigorous procedures are used; (c) to develop consensus guidelines on the optimal use of luminescent dosimeters for clinical practice; and (d) to develop guidelines for special medically relevant uses of TLDs/OSLDs such as mixed photon/neutron field dosimetry, particle beam dosimetry, and skin dosimetry. While this report provides general guidelines for TLD and OSLD processes, the report provides specific details for TLD-100 and nanoDotTM dosimeters because of their prevalence in clinical practice.

Original languageEnglish (US)
Pages (from-to)e19-e51
JournalMedical physics
Volume47
Issue number2
DOIs
StatePublished - Feb 1 2020

Keywords

  • OSLD
  • TLD
  • Task Group
  • dosimetry
  • luminescence

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'AAPM TG 191: Clinical use of luminescent dosimeters: TLDs and OSLDs'. Together they form a unique fingerprint.

Cite this